The MHRA categorizes medicine recalls into three main classes: National Patient Safety Alert (NatPSA)(equivalent to Class 1 Medicines Recall), Class 2, and Class 3. Each class represents a different level of risk, and the urgency of the action required depends on the severity of the defect. There is also a fourth level, known as Medicines Notification: Caution in use (Class 4).

A table explaining the new Medicines Recall and Notification classifications and the associated defect risk classification can be found on the GOV.UK website.

The Recall Process

Once a medicine defect is identified, the MHRA works with manufacturers, wholesalers and healthcare professionals to assess the risk and determine the appropriate recall classification. The MHRA then issues a Medicines Recall or Notification to inform suppliers, healthcare providers, pharmacies, and the public. For urgent recalls, such as a National Patient Safety Alert (NatPSA)(equivalent to Class 1 Medicines Recall), notifications are sent out immediately to ensure the defective products are removed from shelves and recalled from patients as quickly as possible.

Suppliers, clinics, hospitals, and pharmacies are required to follow the recall instructions, which may include stopping the use of the medicine, returning stock, or advising patients to switch to an alternative treatment. Public communication is a key part of the recall process, ensuring that patients are made aware of any risks and advised on what steps to take if they have already used the affected medicine.

Figure 1: The new Medicines Recall and Notification classifications and the associated defect risk classification. Source: MHRA

For healthcare professionals, the presence of falsified medicines in the supply chain can be detrimental to both patient safety and the reputation of their practice. In this article, we will explore the dangers of falsified medicines and how working with a WDA(H) holder like Burlington Pharma can mitigate these risks.

The Threat of Falsified Medicines: Risks to Healthcare Professionals and Patients

Falsified medicines are a growing global concern, with the World Health Organization (WHO) estimating that up to 1 in 10 medical products in low- and middle-income countries are either substandard or falsified. However, this problem is not limited to specific regions—globalization and complex supply chains mean falsified medicines can infiltrate even highly regulated markets.

1. Patient Safety

The most critical concern with falsified medicines is their impact on patient safety. These products may contain incorrect or harmful ingredients, be contaminated, or lack the active pharmaceutical ingredients (API) required to treat a patient’s condition effectively. For example, a falsified antibiotic might not contain enough of the active substance to eradicate an infection, leading to treatment failure or the development of antibiotic resistance.

The use of falsified medicines can result in:

• Adverse drug reactions (ADRs): Patients may experience unexpected side effects or allergic reactions due to the presence of undeclared or incorrect substances.
• Therapeutic failure: Substandard or diluted products may not treat the disease as intended, prolonging illness or worsening conditions.
• Death: In extreme cases, the use of falsified medicines can lead to fatal outcomes, especially in critical therapies like chemotherapy or anti-retroviral treatments.

2. Reputation of Healthcare Practices

For healthcare professionals, unknowingly administering falsified medicines can severely damage the reputation of their practice. Patients trust that healthcare providers deliver safe, reliable treatment. If a falsified medicine is detected or a patient suffers harm, it could lead to legal consequences, loss of patient trust, and even regulatory sanctions for the healthcare provider.

Furthermore, the use of falsified medicines can complicate diagnostic processes. If a patient’s condition does not improve or worsens despite treatment, healthcare professionals may misattribute this to misdiagnosis or incorrect treatment plans, leading to ineffective or delayed treatment.

3. Impact on Public Health

Beyond individual patient outcomes, falsified medicines can undermine public health efforts. The use of ineffective medicines in widespread conditions like malaria, tuberculosis, or HIV can lead to outbreaks, resistance, and the erosion of confidence in the healthcare system.

The Role of WDA(H) Holders in Combatting Falsified Medicines

A Wholesale Dealer’s Authorisation for Human Medicines [WDA(H)] is a license granted in the UK by the Medicines and Healthcare products Regulatory Agency (MHRA) to organisations that distribute human medicines. Holders of this license are required to meet stringent regulatory standards to ensure the safe and compliant distribution of medicines. Burlington Pharma, as a WDA(H) holder, plays a pivotal role in mitigating the risks of falsified medicines entering the supply chain. Here’s how:

1. Ensuring Supply Chain Integrity and Regulatory Compliance

As a WDA(H) holder, Burlington Pharma operates under national and international regulations, such as those established by the MHRA in the UK and the European Medicines Agency (EMA).

WDA(H) holders like Burlington Pharma are subject to rigorous regulatory scrutiny from regulatory agencies and are required to have robust Quality Management Systems in place to ensure that medicines are sourced from legitimate manufacturers and suppliers. This includes verifying that every product in the supply chain meets Good Distribution Practices (GDP), a European and UK standard designed to prevent falsified medicines from entering circulation.

Burlington Pharma conducts thorough due diligence on all suppliers and manufacturers, ensuring that:

• Suppliers are licensed and reputable.
• Medicines are authentic, with documented proof of origin.
• Proper storage and transportation protocols are followed to maintain the integrity of the medicine.

2. Batch Tracking and Traceability

One of the major advantages of working with a WDA(H) holder is the batch-level tracking of medicines. Burlington Pharma provides full traceability, allowing healthcare providers to know exactly where and when a product was sourced, and by whom. This traceability helps in:

• Quickly identifying and isolating any compromised batches in the event of recalls.
• Ensuring that medicines administered to patients are sourced from legitimate channels.
• Preventing counterfeit products from being mixed with authentic stock.

3. Auditing and Supplier Verification

Burlington Pharma frequently conducts supplier audits, ensuring that partners maintain the highest standards of quality control. This proactive approach to supplier risk management prevents falsified medicines from reaching healthcare providers. By working with audited suppliers, healthcare professionals can trust that the medicines they administer to patients have been sourced responsibly and are safe for use.

5. Training and Support

In addition to product procurement, Burlington Pharma provides training and support to healthcare professionals on the best practices for handling medicines, detecting potential falsifications, and ensuring compliance with regulatory requirements. This support enables healthcare providers to be vigilant in their practice, maintaining high standards of patient care and reducing the risk of counterfeit drugs affecting patient outcomes.

Conclusion

Falsified medicines pose a significant threat to both patient safety and the integrity of healthcare practices. For healthcare professionals, the consequences of administering these counterfeit products can be severe, leading to compromised patient outcomes, damage to professional reputation, and public health risks.

By working with a WDA(H) holder like Burlington Pharma, healthcare professionals can ensure that their medicine procurement processes are secure, reliable, and fully compliant with regulatory standards. With its commitment to supply chain integrity, traceability, and auditing, Burlington Pharma helps protect both patients and healthcare providers from the dangers of falsified medicines, allowing them to focus on delivering the best possible care.

Benefits of Outsourcing Medicines Procurement

• Focus on Core Competencies: By delegating procurement, healthcare providers can focus precious resources on delivering patient care, improving clinical outcomes, and enhancing patient satisfaction.
• Cost Reduction: Increased purchasing power and combined economies of scale mean wholesaling pharmacies can often negotiate for better prices with suppliers on your behalf, resulting in significant cost savings for the healthcare facility. Wholesaling pharmacies buying on your behalf also take on a portion of the purchasing risk, reducing the financial burden healthcare facilities may incur when coming up against the risk of dead stock or minimum order quantities.
• Improved Efficiency: Outsourcing can streamline the procurement process, reducing administrative burden and freeing up staff time for patient-focused activities. Wholesaling pharmacies tend to have multiple purchase streams for effective procurement which is time-consuming and costly for healthcare facilities to replicate.
• Enhanced Drug Supply Reliability: A dedicated wholesaling pharmacy can maintain optimal inventory levels, reducing the risk of stock-outs and ensuring a consistent supply of medications.
• Expert Pharmaceutical Management: Specialised wholesaling pharmacies possess in-depth knowledge of the pharmaceutical market, drug regulations, and supply chain management, leading to improved decision-making and risk mitigation. That knowledge can be shared to improve medicines management within the healthcare facility and drive down waste.
• Risk Mitigation: Outsourcing can help mitigate risks associated with drug shortages, counterfeit medications, and regulatory non-compliance.
• Access to Technology: Specialized wholesaling pharmacies often utilise advanced technology to manage inventory, track drug usage, and provide real-time data to healthcare providers.
• Pharmacy Partners. Healthcare facilities may also consider utilising the registered pharmacy to dispense prescriptions issued by their clinicians, streamlining the patient journey as well as improving oversight when it comes to the medicines dispensed for their patients. Bespoke affiliation agreements can make this set up mutually beneficial for both clinic and pharmacy.
• Access to a Pharmacist. Pharmacists are the expert in medicines, and having dedicated access to a pharmacist through an outsourced specialised wholesaling pharmacy service can improve patient safety, help clinicians make more informed treatment decisions and diversify the healthcare facility’s clinical skillset at very little cost.

How Burlington Pharma Can Help

Burlington Pharma is a GPhC-registered Pharmacy with a WDA(H) wholesale license granted by the MHRA. We offer comprehensive medicines procurement solutions as well as a Pharmacy Partner service tailored to the needs of clinics and hospitals.

• Customized Procurement Services: Burlington Pharma works closely with healthcare facilities to understand their unique requirements and develop tailored procurement strategies.
• Competitive Pricing: Leveraging our strong relationships with suppliers, we are able to secure competitive prices on a wide range of medications. We will work closely with you to ensure your procurements needs are met and to budget.
• Efficient Order Processing: Streamlined order processing and delivery systems ensure timely and accurate fulfilment of medication orders.
• Inventory Management: Advanced inventory management systems help optimize stock levels, reduce wastage, and prevent stock-outs.
• Drug Information Services: Burlington Pharma provides access to up-to-date drug information and clinical support to healthcare professionals.
• Regulatory Compliance: As a registered pharmacy with a WDA(H) license, Burlington Pharma adheres to strict regulatory standards set by the GPhC and MHRA, ensuring compliance with all legal requirements.
• Data Analytics: Leveraging data analytics, Burlington Pharma can identify trends in drug usage, and work with you to optimise purchasing decisions and provide valuable insights to optimise your practice.

Key Takeaways:

• Outsourcing medicines procurement can free up valuable resources and improve efficiency within healthcare facilities.
• Specialised wholesaling pharmacies like Burlington Pharma offer expertise, purchasing power, and technology to optimise the procurement process.
• Burlington Pharma provides comprehensive procurement services tailored to the needs of clinics and hospitals.
• By partnering with a specialised wholesaling pharmacy like Burlington Pharma, healthcare organisations can achieve cost savings, enhance drug supply reliability, and improve patient care.